OctoHealth ApS: Financial statements 2023
CVR: 39098547
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
OctoHealth ApS (CVR 39098547) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK -13,577 compared with DKK -2,283 the year before. Equity in the 2023 report amounted to DKK 25,753. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -13,577
- Equity
- DKK 25,753
- Total Assets
- DKK 25,753
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | -14K | 26K | - |
| 2022 | 0 | -2K | -2K | 40K | - |
| 2021 | 0 | -7K | -7K | 2K | - |
| 2020 | 0 | -2K | -2K | 5K | - |
| 2019 | 85K | 82K | -8K | 7K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
OctoHealth ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -2,283.
About OctoHealth ApS
OctoHealth ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2017. The company is registered under the industry Fremstilling af instrumenter og udstyr til måling, afprøvning og navigation. The company was previously named OctoHealth IVS and LLConsult IVS. The management consists of Lise Sperling Pape Haugstaul and Kasper Lundberg Lykkegaard. The company is owned by SENS INNOVATION ApS and Walk With Path Europe ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK -5,171 compared with DKK -144 the year before. Equity in the 2025 report amounted to DKK 20,582.